Trials / Completed
CompletedNCT03017651
An Evaluation of Omega-3 Fatty Acid
An Evaluation of a Proprietary Omega-3 Fatty Acid Incorporated Into a MAG on Blood EPA and DHA Levels: a PK Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This protocol will determine the pK profile of two different omega-3 fatty acid supplements on plasma EPA and DHA levels.
Detailed description
This protocol is to assess the omega-3 blood levels of DHA and EPA following a single dose administration of study products by means of pharmacokinetics over a 24 hour period of time (post-dose).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | OM3-supplement 1 | 1g of OM3-supplement 1 will be given to subjects to look at DHA/EPA blood absorption |
| DIETARY_SUPPLEMENT | OM3-supplement 2 | 1g of OM3-supplement 2 will be given to subjects to look at DHA/EPA blood absorption |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2016-12-01
- Completion
- 2017-05-01
- First posted
- 2017-01-11
- Last updated
- 2017-05-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03017651. Inclusion in this directory is not an endorsement.